Citation Impact

Citing Papers

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
2006 StandoutScience
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Diverse taxa of cyanobacteria produce β- N -methylamino- l -alanine, a neurotoxic amino acid
2005
State of knowledge and concerns on cyanobacterial blooms and cyanotoxins
2013 Standout
Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia
1999
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
2002
Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study
1991
Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy
1998
β-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates
2008
The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases
2001
Familial progressive supranuclear palsy
1995
Neurofibrillary tangle parkinsonian disorders?tau pathology andtau genetics
1999
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Determination of the neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (α-,γ-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms
2009
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
2010
Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease
1999
Axon degeneration mechanisms: commonality amid diversity
2005
Alzheimer's disease
2011 Standout
Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
2008
Genetics of Parkinson's disease
2005
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
2011
Tau‐positive dial Inclusions in Progressive Supranuclear Palsy, Corticobasal Degeneration and Pick's Disease
1999
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration
1999
Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins
2001
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
1988 Nature
Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA
2008
Amyotrophic lateral sclerosis
2011 Standout
Alpha-synuclein and Parkinson's disease
2000
Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
1990
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
2004
Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes
1996
Presymptomatic Hypertension Is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy
1997
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
2000
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
Neuropathological stageing of Alzheimer-related changes
1991 Standout
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
1991 Standout
Decoding ALS: from genes to mechanism
2016 StandoutNature
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
2003
The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases
2004
Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders
1993
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
A Comparative Study on Three Analytical Methods for the Determination of the Neurotoxin BMAA in Cyanobacteria
2012
On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis
1996
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
1988 Standout
Parkinson's disease
2015 Standout
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
2001 Standout
Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis
1989
LC–MS/MS determination of the isomeric neurotoxins BMAA (β-N-methylamino-l-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius
2009
Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome
2006
Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related Pathology
1997
Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue
1992
Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles
1990
Autophagy in Human Health and Disease
2013 Standout
Neuropathology of Alzheimer's disease and other dementias
2001
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease
2009
Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration?
1999
Normal and Pathological Tau Proteins as Factors for Microtubule Assembly
1997
The epidemiology of ALS: a conspiracy of genes, environment and time
2013
Alzheimer's Disease
2010 Standout
Transglutaminase-Induced Cross-Linking of Tau Proteins in Progressive Supranuclear Palsy
2000
Parkinson's Disease
1998 Standout
Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles
1988
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
The Amyloid State of Proteins in Human Diseases
2012 Standout
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging
1990
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases
1992
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Cyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food webs
2010
The number needed to treat: a clinically useful measure of treatment effect
1995
Abnormal Tau proteins in progressive supranuclear palsy
1991
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Neurofibrillary degeneration and neuronal loss in alzheimer's disease
1989
Parkinson's Disease and Parkinsonism: Neuropathology
2012
Neurotoxic cyanobacterial toxins
2009
Oxidative stress: Free radical production in neural degeneration
1994
Analytical techniques for the detection of α-amino-β-methylaminopropionic acid
2012
Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations
1994
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS
2011
Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
1997
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China
2009
Amyotrophic Lateral Sclerosis
2001 Standout
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
1999
Biological fluid biomarkers in neurodegenerative parkinsonism
2009
Distinguishing the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB)
2010
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability
2006
Co‐occurrence of β‐ N ‐methylamino‐ l ‐alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990–2004
2008
Pigmentation genes link Parkinson’s disease to melanoma, opening a window on both etiologies
2008
Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
2007
Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers
1985
The aftermath of boxing
1973
The functional anatomy of basal ganglia disorders
1989 Standout
The genetics of Parkinson's disease: Progress and therapeutic implications
2013
Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement
1994
Corticodentatonigral Degeneration With Neuronal Achromasia
1968
Neurodegenerative Tauopathies
2001 Standout
The `subcortical dementia' of progressive supranuclear palsy
1974
Progressive supranuclear palsy
1971
Copper Active Sites in Biology
2014 Standout
Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex on Guam
1966
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
1992 Standout
A Century of Alzheimer's Disease
2006 StandoutScience
Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
1973 Standout
Neurotoxicity associated with dual actions of homocysteine at the N -methyl- d -aspartate receptor
1997
Apraxia of Lid Opening
1965
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Amyloid Deposits and Amyloidosis
1980 Standout
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
1990 StandoutScience
The Cyanobacteria Derived Toxin Beta-N-Methylamino-L-Alanine and Amyotrophic Lateral Sclerosis
2010
Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
1995
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
2002
?Striato-nigrale Degeneration?
1968
The tau gene A0 allele and progressive supranuclear palsy
1999
Analysis of saliva composition in patients with burning mouth syndrome (BMS) by FTIR spectroscopy
2018
Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy)
1976
Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy
1977
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
2002
Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
1974
Ultrastructure of Neurofibrillary Tangles in Steele-Richardson-Olszewski Syndrome
1973
Excitotoxicity and Amyotrophic Lateral Sclerosis
2005
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
1990 StandoutScience
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
2003
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Progressive supranuclear palsy case report with pathological findings
1969
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 StandoutScience
Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations
1980
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
2001 StandoutScience
Subcortical Dementia
1984
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience

Works of John C. Steele being referenced

The tau H2 haplotype is almost exclusively Caucasian in origin
2004
Observations About Amyotrophic Lateral Sclerosis and the Parkinsonism-Dementia Complex of Guam with Regard to Epidemiology and Etiology
1987
Amyotrophic lateral sclerosis and parkinsonism-dementia from Guam: differences in neurofibrillary tangle distribution and density in the hippocampal formation and neocortex
1994
Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles
1996
A Retinopathy on Guam with High Prevalence in Lytico-Bodig
1989
Pathologic Findings in the Retinal Pigment Epitheliopathy Associated with the Amyotrophic Lateral Sclerosis/Parkinsonism-dementia Complex of Guam
1993
TDP‐43 is consistently co‐localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations
2009
Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam
2004
Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/PDC)
2008
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders
1994
Low frequency of α‐synuclein mutations in familial Parkinson's disease
1998
Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam
1997
Relationship of amyloid ?/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia
1995
Clinically Relevant Patch Test Results in Patients With Burning Mouth Syndrome
2012
Brain amino acid contents are dissimilar in sporadic and Guamanian amyotrophic lateral sclerosis
1990
Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins
1996
Parkinsonism-dementia complex of Guam
2005
On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam
1999
Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus
1998
Progressive Supranuclear Palsy
2005
Neurodegenerative diseases of Guam: Analysis of TAU
1999
Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam
1997
Supranuclear disturbances of ocular motility in Lytico‐Bodig
1988
Amyotrophic lateral sclerosis/parkinsonism-dementia complex in southern Guam: is it disappearing?
1991
Progressive Supranuclear Palsy
1964
Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism–dementia complex and Guadeloupean parkinsonism
2002
2‐Amino‐3‐(methylamino)‐propanoic acid (BMAA) in cycad flour
1990
The ALS/PDC syndrome of Guam and the cycad hypothesis
2008
Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia
2014
Rankless by CCL
2026